康泰医学系统（秦皇岛）股份有限公司2024年年度报告摘要

Core Viewpoint - The company, Kangtai Medical, operates in the medical device industry, focusing on the research, production, and sales of medical diagnostic and monitoring equipment, with a strong emphasis on enhancing operational efficiency and market potential despite weak downstream demand [4]. Company Overview - Kangtai Medical is a high-tech enterprise specializing in medical diagnostic and monitoring equipment, with a product range that includes blood oxygen, electrocardiogram, ultrasound, monitoring, blood pressure, and analytical testing devices, as well as digital health services [4]. - The company has established three main product systems: hospital-use, home-use, and other categories, serving various healthcare settings including hospitals, clinics, community health service centers, and individual households [4]. Financial Performance - The company's main business revenue accounted for 99.22% of total revenue during the reporting period, indicating a strong focus on core operations [4]. - The company received a standard unqualified audit opinion from Deloitte Huayong Accounting Firm, with no changes in the auditing firm during the reporting period [2][3]. Profit Distribution - The board of directors approved a profit distribution plan, proposing a cash dividend of 2.5 yuan (including tax) for every 10 shares, with no bonus shares issued [3]. Shareholder Information - The report includes details on the number of ordinary shareholders and the top 10 shareholders, with no changes in the major shareholders compared to the previous period [4]. Bond Information - The company maintains a long-term credit rating of A+ from United Ratings, with a stable outlook for its bonds [7].